Work

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia

Year: 2010

Type: article

Study design: Clinical Trial

Source: American Journal of Hematology

DOI: 10.1002/ajh.21788

Authors: Irene M. Ghobrial, Wanling Xie, Swaminathan Padmanabhan, Ashraf Badros, Meghan Rourke, Renee Leduc, Stacey Chuma, Janet Kunsman, Diane Warren, Tiffany Poon, Brianna Harris, Amy Sam, Kenneth C. Anderson, Paul G. Richardson, Steven P. Treon, Edie Weller, Jeffrey Matous

Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Roswell Park Comprehensive Cancer Center, University of Maryland, Baltimore, Rocky Mountain Cancer Centers

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2128139299

FWCI: 3.756

Cites: 24

Cited by: 148

Related to: 10